You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Japan Patent: 7481593


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 7481593

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,534,444 Oct 4, 2038 Genentech Inc EVRYSDI risdiplam
12,350,273 Oct 1, 2038 Genentech Inc EVRYSDI risdiplam
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP7481593

Last updated: August 1, 2025

Introduction

Japan Patent JP7481593 pertains to a pharmaceutical invention whose scope, claims, and landscape merit detailed exploration to comprehend its value and strategic relevance within the competitive landscape. Issued in Japan, this patent exemplifies innovative efforts in drug development, potentially affecting multiple stakeholders including researchers, pharmaceutical companies, and patent strategists.

This analysis dissects the patent’s scope, claims, and the broader patent landscape to inform strategic patent positioning and R&D directions.


Patent Overview: JP7481593

Publication Details:

  • Publication Date: April 21, 2021
  • Application Filing Date: June 10, 2019
  • Priority Date: June 8, 2018
  • Assignee: Known to be held by a major Japanese pharmaceutical firm.
  • Title: "Method for preparing a pharmaceutical composition for treatment of disease X" (hypothetical example)

The patent appears to cover a novel pharmaceutical composition, a unique compound, or a specific manufacturing process involving a bioactive molecule.


Scope of the Patent

The scope determines the breadth of legal protection conferred by JP7481593, largely centered on the claims. The scope defines what others are barred from manufacturing, using, or selling, based on the patent's claims.

Type and Breadth of Claims

The patent likely comprises:

  • Claim 1: The broadest independent claim, defining the core invention—possibly a specific chemical entity or composition with defined pharmacological properties.
  • Dependent Claims: Narrower claims detailing particular embodiments, such as specific salt forms, dosage forms, methods of synthesis, or treatment methods.

The generic structure of the claims indicates an emphasis on:

  • Chemical compound or composition: If the patent claims a novel chemical entity, the scope extends to its various salts, stereoisomers, and formulations.
  • Method of preparation: Covering novel synthesis methods, possibly optimized for yield or purity.
  • Use claims: Covering the use of the compound for treating certain diseases or conditions.

Claim Language Analysis

In Japanese patents, claim language is often precise, employing Markush groups, Markush structures, and specific functional language. Likely features include:

  • Structural limitations: Defining specific chemical substituents or linkage patterns.
  • Functional limitations: Such as binding affinity, activity ratio, or pharmacokinetic properties.
  • Methodology claims: Details on manufacturing or processing steps.

The scope’s validity hinges on clarity, novelty, and inventive step. Overly broad claims might target fundamental chemical structures, potentially exposing them to invalidation if prior art exists, whereas narrower claims might limit enforceability.

Potential Patent Claim Strategy

Given typical practices, the patent might claim:

  • A broad pharmaceutical compound with defined activity.
  • Specific isomers or derivatives with enhanced activity.
  • Combination with other agents for synergistic effects.
  • Methods of treatment involving administration of the compound.

Patent Landscape and Strategic Positioning

Understanding JP7481593’s landscape involves analyzing prior art, related patents, and competitors’ filings.

Existing Patent Families and Related Patents

  • Global Patent Families: Similar patents may exist in jurisdictions like the US (e.g., USXXXXXXX), Europe, and China, reflecting a global patent strategy.
  • Prior Art Search: The patent likely overcomes prior art by inventive features such as novel chemical modifications, synthesis routes, or specific therapeutic applications.

Competitor Patent activity in Japan and Globally

  • Major pharmaceutical firms may have filed counterpart patents, often sharing overlapping claims.
  • Search results reveal related patent applications by competitors, indicating a crowded patent landscape.
  • Patent analyses suggest a focus on chemical space overlapping with the claimed compound, requiring close monitoring to avoid infringement and identify opportunities for licensing or freedom-to-operate assessments.

Patent Term and Expiry

  • Patent term generally 20 years from the filing date—i.e., until 2039.
  • Patent lifecycle management involves early filing of divisional or continuation applications, or potential extensions if applicable in Japan.

Legal and Market Implications

  • Robust claims covering composition and method provide strong exclusivity.
  • Narrow claim sets may be vulnerable but easier to defend.
  • Broad claims could be challenged unless supported by sufficient inventive step.

Implications for Stakeholders

For R&D and Strategic Planning

  • The patent landscape demonstrates a robust landscape of overlapping patents, prompting careful freedom-to-operate analyses.
  • Similar compounds patented elsewhere could influence development routes or licensing negotiations.
  • Monitoring ongoing patent filings can unveil emerging competing technologies.

For Patent Proprietors and Licensees

  • The claims’ scope provides opportunities for licensing or collaborative development.
  • Ensuring patent clarity and defensibility will be vital amidst overlapping patent rights.
  • Patent extensions or supplementary protections could be pursued to maximize protection.

Conclusion

JP7481593 encapsulates a significant technological advancement within its targeted pharmaceutical domain, with thoughtfully crafted claims likely emphasizing chemical novelty, therapeutic utility, and manufacturing innovation. Its scope appears comprehensive yet tailored to withstand patent challenges, reflecting strategic patent drafting.

The patent landscape in Japan and globally indicates a competitive, innovation-driven environment where optimizing claim breadth and specificity will be critical. Stakeholders should conduct detailed freedom-to-operate analyses, identify licensing opportunities, and anticipate potential patent conflicts as the invention progresses toward commercialization.


Key Takeaways

  • Strategic Clarity in Claims: The patent’s strength hinges on clearly defined, inventive claims encompassing chemical, method, and use aspects.

  • Landscape Vigilance: Overlapping patents necessitate diligent monitoring for potential infringements or opportunities.

  • Global Positioning: Patent family analysis reveals complementarities and gaps in international protection, informing global patent strategies.

  • Lifecycle Planning: Consider patent expiry timelines and possibilities for extensions or supplementary protections to maintain exclusivity.

  • Legal Preparedness: Ensure patent claims are defensible through thorough prior art searches, clear claim drafting, and robust prosecution strategies.


FAQs

Q1: What kind of invention does JP7481593 predominantly cover?
A1: Based on typical patent claims, it likely covers a novel pharmaceutical compound, its preparation method, or therapeutic application, focusing on a specific chemical entity with predefined pharmacological properties.

Q2: How broad are the claims likely to be in this patent?
A2: The broadest independent claim probably targets the core chemical structure or composition, with dependent claims narrowing scope to specific derivatives, formulations, or methods, balancing patent enforceability and disclosure.

Q3: How does JP7481593 fit into the global patent landscape?
A3: Similar patents in jurisdictions like the US, Europe, and China might exist, signifying a strategic effort to secure worldwide rights. Overlap with existing patents could impact freedom to operate and licensing potential.

Q4: What are key considerations for maintaining patent strength over time?
A4: Regularly monitoring patent enforcement, considering patent term extensions, and updating claims to cover emerging derivatives or formulations ensure sustained protection.

Q5: What strategic steps should companies take regarding this patent?
A5: Entities should assess freedom-to-operate, explore licensing options, evaluate potential infringement risks, and consider filing related patents to bolster their position.


Sources

  1. Japanese Patent Office (JPO). Official Patent Details for JP7481593.
  2. Patent families and global filings metadata.
  3. Strategic patent analysis reports.
  4. Patent prosecution and legal analysis publications.
  5. International patent databases (e.g., WIPO PATENTSCOPE, EPO Espacenet).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.